Latest News

Celltrion Finalizes Clinical Trials for Remsima SC, Planning to File a Marketing Authorization Application to the EMA in H2


INCHEON, South Korea–(BUSINESS WIRE)–#Celltrion–Celltrion finalizes clinical trials for the patient convenience-enhanced Remsima SC, planning to file a marketing authorization application to the EMA

Source link

Related posts

植物性饮食或许能降低死亡风险

Newsemia

Senza Omnia Stimulator for Chronic Pain, with Widest Frequency Range, FDA Approved

Newsemia

Cellular Incubator for Implantation Into Body

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World